Condition
Perioral Rhytids
Total Trials
5
Recruiting
0
Active
2
Completed
2
Success Rate
100.0%+13% vs avg
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 27/100
Termination Rate
0.0%
0 terminated out of 5 trials
Success Rate
100.0%
+13.4% vs benchmark
Late-Stage Pipeline
20%
1 trials in Phase 3/4
Results Transparency
50%
1 of 2 completed with results
Key Signals
1 with results100% success
Data Visualizations
Phase Distribution
4Total
Not Applicable (3)
P 4 (1)
Trial Status
Active Not Recruiting2
Completed2
Unknown1
Trial Success Rate
100.0%
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (5)
Showing 5 of 5 trials
NCT07492277Active Not Recruiting
A Non-Interventional PMCF Study Evaluating Croma Revitalis for the Correction of Fine Lines
NCT06872359Not ApplicableActive Not Recruiting
Evaluation of Performance and Safety of Injectable KIO017 Device Range for Facial Tissue Filling
NCT03923634Not ApplicableCompleted
Princess® RICH for the Correction of Fine Lines
NCT03092219Not ApplicableCompletedPrimary
RHA Redensity - Perioral Rhytids
NCT02818556Phase 4UnknownPrimary
A Clinical Study Comparing Restylane® Silk and Belotero Balance® for the Treatment of Superficial, Vertical Perioral Lines
Showing all 5 trials